United States · FDA National Drug Code directory
Hydroxyzine Pamoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71205-087_a4ff5eef-8452-42aa-8127-32e3c56c2b2b
- Product NDC
- 71205-087
- Form
- CAPSULE
- Composition / generic term
- Hydroxyzine Pamoate
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19960715
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROXYZINE PAMOATE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 CAPSULE in 1 BOTTLE, PLASTIC (71205-087-15) · 71205-087-15
- 20 CAPSULE in 1 BOTTLE, PLASTIC (71205-087-20) · 71205-087-20
- 30 CAPSULE in 1 BOTTLE, PLASTIC (71205-087-30) · 71205-087-30
- 60 CAPSULE in 1 BOTTLE, PLASTIC (71205-087-60) · 71205-087-60
- 90 CAPSULE in 1 BOTTLE, PLASTIC (71205-087-90) · 71205-087-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →